Rapamycin

CARDIFF, U.K., August 19, 2026 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) announced a major recruitment milestone for its Serenta registrational...

LONDON, United Kingdom, June 29, 2026 Biodexa Pharmaceuticals PLC announced that Health Canada has approved the expansion of its...